Identification of a New Psychoactive Substance in Seized Material: the Synthetic Opioid N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide (Acrylfentanyl)
Overview
Pharmacology
Affiliations
Among the new psychoactive substances (NPS) that have recently emerged on the market, many of the new synthetic opioids have shown to be particularly harmful. A new synthetic analogue of fentanyl, N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide (acrylfentanyl), was identified in powder from a seized capsule found at a forensic psychiatric ward in Denmark. Gas chromatography with mass spectrometry (GC-MS) identified a precursor to synthetic fentanyls, N-phenyl-1-(2-phenylethyl)piperidin-4-amine; however, the precursor 1-(2-phenethyl)piperidin-4-one, was not detected. Analysis of the electron impact mass spectrum of the main, unknown chromatographic peak (GC) tentatively identified an acryloyl analogue of fentanyl. Further analyses by quadrupole time-of-flight high resolution mass spectrometry (QTOF-MS), matrix-assisted laser ionization Orbitrap mass spectrometry (MALDI-Orbitrap-MS), nuclear magnetic resonance spectroscopy (NMR), and infra-red spectroscopy (IR) confirmed the presence of acrylfentanyl (also known as acryloylfentanyl). Quantitative analysis with liquid chromatography and triple quadrupole mass spectrometry (LC-MS/MS) determined the content of acrylfentanyl in the powder, equal to 88.3 mass-% acrylfentanyl hydrochloride. An impurity observed by NMR was identified as triethylamine hydrochloride. Acrylfentanyl is sold on the Internet as a 'research chemical'. Like other synthetic fentanyls, such as acetylfentanyl, it poses a serious risk of fatal intoxication. Copyright © 2016 The Authors. Drug Testing and Analysis Published by John Wiley & Sons Ltd.
Feeney W, Moorthy A, Sisco E Forensic Chem. 2022; 31.
PMID: 36578315 PMC: 9793444. DOI: 10.1016/j.forc.2022.100459.
Synthetic opioids: a review and clinical update.
Shafi A, Berry A, Sumnall H, Wood D, Tracy D Ther Adv Psychopharmacol. 2022; 12:20451253221139616.
PMID: 36532866 PMC: 9747888. DOI: 10.1177/20451253221139616.
West H, Fitzgerald J, Hopkins K, Leeming M, DiRago M, Gerostamoulos D Drug Test Anal. 2022; 14(9):1576-1586.
PMID: 35562123 PMC: 9542064. DOI: 10.1002/dta.3284.
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.
Mohr A, Logan B, Fogarty M, Krotulski A, Papsun D, Kacinko S J Anal Toxicol. 2022; 46(6):e116-e185.
PMID: 35445267 PMC: 9282356. DOI: 10.1093/jat/bkac023.
Tsochatzis E, Alberto Lopes J, Holland M, Reniero F, Palmieri G, Guillou C Molecules. 2021; 26(4).
PMID: 33546439 PMC: 7913736. DOI: 10.3390/molecules26040793.